BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 21719533)

  • 1. PAK1-Nck regulates cyclin D1 promoter activity in response to prolactin.
    Tao J; Oladimeji P; Rider L; Diakonova M
    Mol Endocrinol; 2011 Sep; 25(9):1565-78. PubMed ID: 21719533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosyl phosphorylated PAK1 regulates breast cancer cell motility in response to prolactin through filamin A.
    Hammer A; Rider L; Oladimeji P; Cook L; Li Q; Mattingly RR; Diakonova M
    Mol Endocrinol; 2013 Mar; 27(3):455-65. PubMed ID: 23340249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin-induced PAK1 tyrosyl phosphorylation promotes FAK dephosphorylation, breast cancer cell motility, invasion and metastasis.
    Hammer A; Diakonova M
    BMC Cell Biol; 2016 Aug; 17(1):31. PubMed ID: 27542844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAK1 translocates into nucleus in response to prolactin but not to estrogen.
    Oladimeji P; Diakonova M
    Biochem Biophys Res Commun; 2016 Apr; 473(1):206-211. PubMed ID: 27003261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adapter protein SH2B1beta binds filamin A to regulate prolactin-dependent cytoskeletal reorganization and cell motility.
    Rider L; Diakonova M
    Mol Endocrinol; 2011 Jul; 25(7):1231-43. PubMed ID: 21566085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IV.
    Rider L; Oladimeji P; Diakonova M
    Mol Endocrinol; 2013 Jul; 27(7):1048-64. PubMed ID: 23744893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of tyrosine 285 of PAK1 facilitates βPIX/GIT1 binding and adhesion turnover.
    Hammer A; Oladimeji P; De Las Casas LE; Diakonova M
    FASEB J; 2015 Mar; 29(3):943-59. PubMed ID: 25466889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRL activates the cyclin D1 promoter via the Jak2/Stat pathway.
    Brockman JL; Schroeder MD; Schuler LA
    Mol Endocrinol; 2002 Apr; 16(4):774-84. PubMed ID: 11923474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Janus kinase 2 is required for expression and nuclear accumulation of cyclin D1 in proliferating mammary epithelial cells.
    Sakamoto K; Creamer BA; Triplett AA; Wagner KU
    Mol Endocrinol; 2007 Aug; 21(8):1877-92. PubMed ID: 17519353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt phosphorylation of serine 21 on Pak1 modulates Nck binding and cell migration.
    Zhou GL; Zhuo Y; King CC; Fryer BH; Bokoch GM; Field J
    Mol Cell Biol; 2003 Nov; 23(22):8058-69. PubMed ID: 14585966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin signals via Stat5 and Oct-1 to the proximal cyclin D1 promoter.
    Brockman JL; Schuler LA
    Mol Cell Endocrinol; 2005 Jul; 239(1-2):45-53. PubMed ID: 15885880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion.
    Hammer A; Diakonova M
    Adv Exp Med Biol; 2015; 846():97-137. PubMed ID: 25472536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear factor of activated T cells c1 mediates p21-activated kinase 1 activation in the modulation of chemokine-induced human aortic smooth muscle cell F-actin stress fiber formation, migration, and proliferation and injury-induced vascular wall remodeling.
    Kundumani-Sridharan V; Singh NK; Kumar S; Gadepalli R; Rao GN
    J Biol Chem; 2013 Jul; 288(30):22150-62. PubMed ID: 23737530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells.
    Balasenthil S; Sahin AA; Barnes CJ; Wang RA; Pestell RG; Vadlamudi RK; Kumar R
    J Biol Chem; 2004 Jan; 279(2):1422-8. PubMed ID: 14530270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AND-34/BCAR3, a GDP exchange factor whose overexpression confers antiestrogen resistance, activates Rac, PAK1, and the cyclin D1 promoter.
    Cai D; Iyer A; Felekkis KN; Near RI; Luo Z; Chernoff J; Albanese C; Pestell RG; Lerner A
    Cancer Res; 2003 Oct; 63(20):6802-8. PubMed ID: 14583477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Cbl-Nck and Nck-Pak1 interactions in myeloid FcgammaRII signaling.
    Izadi KD; Erdreich-Epstein A; Liu Y; Durden DL
    Exp Cell Res; 1998 Dec; 245(2):330-42. PubMed ID: 9851874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK2 tyrosine kinase phosphorylates PAK1 and regulates PAK1 activity and functions.
    Rider L; Shatrova A; Feener EP; Webb L; Diakonova M
    J Biol Chem; 2007 Oct; 282(42):30985-96. PubMed ID: 17726028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways.
    Acosta JJ; Muñoz RM; González L; Subtil-Rodríguez A; Dominguez-Caceres MA; García-Martínez JM; Calcabrini A; Lazaro-Trueba I; Martín-Pérez J
    Mol Endocrinol; 2003 Nov; 17(11):2268-82. PubMed ID: 12907754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the Nck adapter protein with p21-activated kinase (PAK1).
    Bokoch GM; Wang Y; Bohl BP; Sells MA; Quilliam LA; Knaus UG
    J Biol Chem; 1996 Oct; 271(42):25746-9. PubMed ID: 8824201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Activation of ERα by Estrogen and Prolactin in Breast Cancer Cells Requires Tyrosyl Phosphorylation of PAK1.
    Oladimeji P; Skerl R; Rusch C; Diakonova M
    Cancer Res; 2016 May; 76(9):2600-11. PubMed ID: 26944939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.